LifeStance Health Group (NASDAQ:LFST) PT Lowered to $8.00 at JPMorgan Chase & Co.

LifeStance Health Group (NASDAQ:LFST) had its price target reduced by JPMorgan Chase & Co. from $10.00 to $8.00 in a report published on Friday, Benzinga reports. They currently have a neutral rating on the stock.

LifeStance Health Group Stock Performance

Shares of LFST opened at $6.20 on Friday. The company’s 50 day simple moving average is $6.28 and its 200-day simple moving average is $7.72. The firm has a market cap of $2.35 billion, a PE ratio of -11.92 and a beta of 1.08. LifeStance Health Group has a 12-month low of $4.22 and a 12-month high of $9.59. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.17.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Wednesday, November 8th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.10). LifeStance Health Group had a negative return on equity of 12.59% and a negative net margin of 18.72%. The business had revenue of $262.90 million for the quarter, compared to analysts’ expectations of $255.18 million. During the same period in the previous year, the business posted ($0.11) earnings per share. The company’s revenue for the quarter was up 20.8% on a year-over-year basis. As a group, equities analysts predict that LifeStance Health Group will post -0.44 EPS for the current year.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Kevin Michael Mullins sold 80,977 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $6.13, for a total value of $496,389.01. Following the transaction, the insider now owns 4,836,306 shares of the company’s stock, valued at $29,646,555.78. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, insider Ann Varanakis sold 5,661 shares of the firm’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $7.60, for a total value of $43,023.60. Following the completion of the sale, the insider now owns 168,441 shares in the company, valued at $1,280,151.60. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Kevin Michael Mullins sold 80,977 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $6.13, for a total value of $496,389.01. Following the transaction, the insider now owns 4,836,306 shares in the company, valued at approximately $29,646,555.78. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 212,237 shares of company stock worth $1,389,099. 8.50% of the stock is currently owned by insiders.

Institutional Trading of LifeStance Health Group

A number of institutional investors have recently modified their holdings of the business. Stockbridge Partners LLC acquired a new stake in LifeStance Health Group in the first quarter valued at $53,529,000. Brown Advisory Inc. acquired a new stake in shares of LifeStance Health Group in the third quarter valued at about $28,140,000. Vanguard Group Inc. boosted its holdings in LifeStance Health Group by 79.6% during the first quarter. Vanguard Group Inc. now owns 6,202,930 shares of the company’s stock worth $62,711,000 after buying an additional 2,749,277 shares in the last quarter. BlackRock Inc. grew its position in LifeStance Health Group by 36.1% during the second quarter. BlackRock Inc. now owns 7,093,100 shares of the company’s stock worth $64,760,000 after buying an additional 1,879,857 shares during the period. Finally, FMR LLC grew its position in LifeStance Health Group by 6.7% during the third quarter. FMR LLC now owns 28,178,666 shares of the company’s stock worth $193,587,000 after buying an additional 1,758,427 shares during the period. 76.98% of the stock is currently owned by hedge funds and other institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.